Novartis strikes $1.1B deal with China’s Baiyu for a small molecule cancer contender

October 23, 2024

Regeneron is market winner in COVID-19 antibodies with $2.6B sales

August 12, 2021

FDA Approves Welireg-Keytruda Combination for Adjuvant Treatment of Clear Cell Renal Cell Carcinoma

June 16, 2026

Must Read

Top 10 Drivers Behind Site-less Clinical Trials

October 15, 2026

Multi-Omics and the Next Generation of Drug Discovery

October 15, 2026

How Foundation Models Are Transforming Drug Discovery

October 15, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Argenx Scraps Phase III Sjögren Study Over Predicted Efficacy Failure

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

BioNTech’s mRNA cancer vaccine fails phase 3 test

BMS Reports Twin Phase 3 Wins in Lung Disease And Solid Tumor

MimiVax’s brain cancer vaccine misses phase 2b goal, but CEO sees a path forward in younger patients

Cerevance’s Solengepras Meets Phase 3 Goal in Parkinson’s Disease Trial

Roche Signs Huge Deal With Rona, Joins ALK7 Obesity Race

Theramex purchases Asieris’ innovative cervical lesion treatment for up to $250 million

Novartis agrees to pay Abogen $7.8 billion for its in vivo autoimmune T-cell engager

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Top 10 Drivers Behind Site-less Clinical Trials

Multi-Omics and the Next Generation of Drug Discovery

How Foundation Models Are Transforming Drug Discovery

Top 10 AI Trends Reshaping Precision Medicine

Tag: BioNTech’s

BioNTech’s mRNA cancer vaccine fails phase 3 test

Editor Picks

Novartis strikes $1.1B deal with China’s Baiyu for a small molecule cancer contender

Regeneron is market winner in COVID-19 antibodies with $2.6B sales

FDA Approves Welireg-Keytruda Combination for Adjuvant Treatment of Clear Cell Renal Cell Carcinoma

Must Read

Top 10 Drivers Behind Site-less Clinical Trials

Multi-Omics and the Next Generation of Drug Discovery

How Foundation Models Are Transforming Drug Discovery

Hot Topics

About Us

Follow Us